Etoposide drug data and news

---

Hycamtin® More Convenient than Etoposide in Small Cell Lung ...  May 5, 2006
...agent cisplatin (Platinol®) produce nearly equivalent outcomes with increased convenience compared to the intravenous form of etoposide (VePesid®) plus ... - Cancer Consultants (press release),

Camptosar®/Carboplatin Improves Progression-Free Survival over ...  Apr 21, 2006
...of Camptosar® (irinotecan) plus Paraplatin® (carboplatin) appears to improve progression-free survival compared with VePesid® (etoposide) plus carboplatin ... - Cancer Consultants (press release),

Inhibiting cell process may give cancer drug a boost  May 3, 2006
In addition, treatment with ML-7 in combination with etoposide, a chemotherapy drug used to treat solid tumors, enhanced the ability of etoposide to kill ... - News-Medical.net,

Rituxan® Improves Outcomes of Young Patients with Good-Prognosis ...  May 1, 2006
Four chemotherapy regimens were included: CHOP-21, CHOEP-21 (added etoposide), MACOP-B (cyclophosphamide, doxorubicin, methotrexate, oncovin, bleomycin, and ... - Cancer Consultants (press release),

Lung cancer CPT-11/SN-38 resistance marked by ABCG2 expression  Apr 20, 2006
..."Because H23/SN-38 cells show cross resistance to certain anticancer drugs, such as topotecan, etoposide, doxorubicin and mitoxantrone, ... - Therapeutics Daily (subscription) (press release),

Survival Improving for Patients with Stage IV Follicular Lymphoma  Apr 17, 2006
The third protocol evaluated alternating non-cross resistant regimes with the addition of etoposide, cytarabine, cisplatin and mitoxantrone, the fourth added ... - Cancer Consultants (press release), m/releases/2005/12/051213225424.htm" >National Study Improves Outcome For Pediatric Acute Myeloid ...  Dec 14, 2005
Science Daily (press release) ...multi-center AML02 trial randomly assigns patients to receive either high- or low-dose treatment with cytarabine (A), daunorubicin (D), and etoposide (E) as ...

Age Makes Little Difference in Outcomes for Non-Hodgkin's Lymphoma ...  Dec 12, 2005
DG News ...who relapsed and underwent autologous stem cell transplant following BEAM conditioning, which combines BCNU (carmustine), etoposide, cytosine arabinoside, and ...

Tandem High-Dose Chemotherapy Superior to Dose-Dense Chemotherapy ...  Dec 5, 2005
Cancer Consultants (press release), Following 2 cycles of EP, patients in the tandem transplant arm received 2 cycles of high-dose etoposide, cyclophosphamide and thiotepa with stem cell support. ...

Patients With Unfavorable Risk Hodgkin’s Lymphoma May Not ...  Dec 19, 2005
Cancer Consultants (press release), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) is a more intensive regimen which has also been evaluated ...

Patients with Unfavorable Risk Hodgkin’s Lymphoma May Not ...  Dec 20, 2005
Cancer Consultants (press release), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) is a more intensive regimen that has also been ...

ASH: Oral Targeted Agent Boosts Remissions in Poor-Prognosis AML  Dec 14, 2005
MedPage Today, Patients whose remissions lasted one to six months received the MEC regimen (consisting of mitoxantrone, etoposide, and cytarabine), while those whose ...

Intensive Chemotherapy Regimen Shows Promise for Germ Cell Tumors  Dec 5, 2005
Cancer Consultants (press release), ...of cisplatin, vincristine, bleomycin, and carboplatin, followed by one cycle of vincristin and bleomycin and three cycles of bleomycon, etoposide, and cisplatin ...

Induction Chemotherapy and Concomitant Chemoradiotherapy Promising ...  Dec 6, 2005
Cancer Consultants (press release), ...gemcitabine and vinorelbine. This was followed by oral etoposide and cisplatin given concurrently with radiation therapy. 29 patients ...

BiovaxID Vaccine Therapy Of Follicular Lymphoma In First Remission ...  Dec 4, 2005
Medical News Today (press release), ...non-Hodgkin's lymphoma are being treated with BiovaxID immunotherapy following PACE [Prednisone, Doxorubicin, Cyclophosphamide, and Etoposide (ProMACE without ...

Caution should be exercised when administering ETOPOPHOS with drugs that are known to inhibit phosphatase activities (e.g., levamisole hydrochloride). High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.